{"id":"W4381383517","doi":"10.1093/bjd/ljad162.025","title":"402 Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Placebo; Eczema Area and Severity Index; Randomized controlled trial; Clinical endpoint; Internal medicine; Clinical trial; Population; Clinical efficacy; Gastroenterology; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004780794,0.0008110263,0.002325983,0.0002394826,0.0004401015,0.0009874137,0.0004865739,0.001229317,0.002403526],"category_scores_gemma":[0.002404251,0.000369933,0.003112986,0.0003173399,0.0006161985,0.0006366367,0.0003473458,0.002014628,0.0003544176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004687372,"about_ca_system_score_gemma":0.0009315579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004290076,"about_ca_topic_score_gemma":0.001629385,"domain_scores_codex":[0.9985437,0.0008687506,0.0001732313,0.0001380579,0.0001686606,0.0001076297],"domain_scores_gemma":[0.9981362,0.0006870613,0.0005657412,0.0001524041,0.0001767956,0.000281735],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8712118,0.01523734,0.01428162,0.003530167,0.007362569,0.0001419921,0.0002155749,0.0007809639,0.01533209,0.0001838002,0.002086209,0.06963581],"study_design_scores_gemma":[0.736732,0.2287448,0.02484426,0.0003072549,0.003158525,0.0002155048,0.00009127301,0.0005220748,0.002159792,0.0002293205,0.002957907,0.00003729095],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9770686,0.01548427,0.000906154,0.0004476499,0.0001744982,0.003415313,0.001036028,0.00006338973,0.001404024],"genre_scores_gemma":[0.9855441,0.005500244,0.001966114,0.001016959,0.0002167778,0.00369273,0.001127805,0.00001767748,0.0009175825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004780794,"threshold_uncertainty_score":0.02528358,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06020217488123019,"score_gpt":0.3610843554295485,"score_spread":0.3008821805483183,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}